Nuveen LLC Invests $17.22 Million in Celsius Holdings Inc. $CELH

Key Points

• Nuveen LLC has acquired a new stake in Celsius Holdings Inc., purchasing 483,515 shares valued at approximately $17.2 million, bringing its total ownership to 0.19% of the company.
• Celsius reported a significant earnings beat with $0.47 EPS compared to a consensus estimate of $0.23, and generated $739.3 million in revenue, surpassing analyst expectations.
• Morgan Stanley raised its price target on Celsius shares from $50.00 to $65.00, maintaining a "buy" rating, reflecting positive sentiment among analysts.

Nuveen LLC purchased a new position in shares of Celsius Holdings Inc. (NASDAQ:CELH - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 483,515 shares of the company's stock, valued at approximately $17,223,000. Nuveen LLC owned about 0.19% of Celsius as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Triumph Capital Management increased its position in Celsius by 41.5% during the fourth quarter. Triumph Capital Management now owns 40,420 shares of the company's stock worth $1,065,000 after purchasing an additional 11,863 shares during the last quarter. Fifth Third Bancorp raised its stake in shares of Celsius by 62.9% in the 1st quarter. Fifth Third Bancorp now owns 1,725 shares of the company's stock valued at $61,000 after acquiring an additional 666 shares during the period. GAMMA Investing LLC raised its stake in shares of Celsius by 4,164.4% in the 1st quarter. GAMMA Investing LLC now owns 73,092 shares of the company's stock valued at $2,604,000 after acquiring an additional 71,378 shares during the period. Oppenheimer & Co. Inc. raised its stake in shares of Celsius by 14.0% in the 1st quarter. Oppenheimer & Co. Inc. now owns 9,760 shares of the company's stock valued at $348,000 after acquiring an additional 1,199 shares during the period. Finally, Cambridge Investment Research Advisors Inc. raised its stake in shares of Celsius by 21.4% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 45,517 shares of the company's stock valued at $1,621,000 after acquiring an additional 8,009 shares during the period. Institutional investors and hedge funds own 60.95% of the company's stock.

Celsius Stock Down 1.6%

CELH stock traded down $0.9910 during mid-day trading on Monday, hitting $60.5290. 1,069,890 shares of the company were exchanged, compared to its average volume of 8,165,875. The company has a market capitalization of $15.61 billion, a PE ratio of 163.96, a price-to-earnings-growth ratio of 1.40 and a beta of 1.40. The company has a current ratio of 2.11, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Celsius Holdings Inc. has a twelve month low of $21.10 and a twelve month high of $63.00. The firm has a fifty day simple moving average of $48.07 and a 200 day simple moving average of $38.60.

Celsius (NASDAQ:CELH - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.24. The company had revenue of $739.30 million during the quarter, compared to analyst estimates of $632.13 million. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The firm's revenue for the quarter was up 83.9% compared to the same quarter last year. During the same period last year, the business earned $0.28 EPS. On average, research analysts forecast that Celsius Holdings Inc. will post 0.89 earnings per share for the current fiscal year.

Insider Buying and Selling at Celsius

In other news, major shareholder Deborah Desantis sold 100,000 shares of the firm's stock in a transaction dated Thursday, July 31st. The shares were sold at an average price of $47.50, for a total value of $4,750,000.00. Following the transaction, the insider directly owned 17,717,770 shares in the company, valued at approximately $841,594,075. This trade represents a 0.56% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Jarrod Langhans sold 5,000 shares of the firm's stock in a transaction dated Monday, August 18th. The stock was sold at an average price of $60.00, for a total transaction of $300,000.00. Following the completion of the transaction, the chief financial officer owned 104,227 shares in the company, valued at approximately $6,253,620. The trade was a 4.58% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 1,116,141 shares of company stock valued at $52,541,605. Corporate insiders own 2.55% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on CELH shares. Needham & Company LLC raised their target price on shares of Celsius from $55.00 to $60.00 and gave the company a "buy" rating in a research note on Thursday, August 7th. Wall Street Zen downgraded shares of Celsius from a "buy" rating to a "hold" rating in a research note on Sunday, August 17th. Roth Capital reissued a "buy" rating and issued a $52.00 target price (up previously from $46.00) on shares of Celsius in a research note on Thursday, June 26th. Stephens reissued an "overweight" rating on shares of Celsius in a research note on Monday, August 11th. Finally, TD Cowen raised shares of Celsius from a "hold" rating to a "buy" rating and raised their price target for the company from $37.00 to $55.00 in a report on Monday, June 16th. Fifteen investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $52.28.

Celsius Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.